Gastrointestinal reactions and rotavirus vaccination based upon analysis of the Vaccine Adverse Events Reporting System (VAERS) database for 1999. A model for the calculation of the incidence rates and statistical significance of adverse events following immunization

Hepato-Gastroenterology

Volumn 51, Issue 56, 2004, Pages 465-469

  Geier, David A ^a   Geier, Mark R ^b,c  

^a MedCon Inc   (United States)

^b Genetic Centers of America   (United States)

^c NONE   (United States)

Author keywords

Adverse reaction; Gastroenterological; Rotavirus vaccine; VAERS

Indexed keywords

DIPHTHERIA PERTUSSIS TETANUS VACCINE; HEPATITIS B VACCINE; LIVE VACCINE; POLIOMYELITIS VACCINE; ROTAVIRUS VACCINE; VIRUS VACCINE;

ARTICLE; CALCULATION; DRUG MONITORING; DRUG SURVEILLANCE PROGRAM; GASTROENTERITIS; GASTROINTESTINAL DISEASE; GASTROINTESTINAL HEMORRHAGE; HUMAN; IMMUNIZATION; INCIDENCE; INTUSSUSCEPTION; MAJOR CLINICAL STUDY; MODEL; PRIORITY JOURNAL; ROTAVIRUS; STATISTICAL ANALYSIS; VACCINATION; VIRUS INFECTION;

ADVERSE DRUG REACTION REPORTING SYSTEMS; CHI-SQUARE DISTRIBUTION; DATABASES, FACTUAL; GASTROINTESTINAL DISEASES; HEPATITIS B VACCINES; HUMANS; POLIOVIRUS VACCINE, ORAL; RETROSPECTIVE STUDIES; ROTAVIRUS VACCINES;

EID: 1542770986     PISSN: 01726390     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Advisory Committee on Immunization Practices: Rotavirus vaccine for the prevention of rotavirus gastroenteritis among children: recommendations of the Advisory Committee on Immunization Practices (ACIP). Morb Mortal Wkly Rep 1999; 48(RR-2):1-20.
2. American Academy of Pediatrics: Prevention of rotavirus disease: guidelines for use of rotavirus vaccine. Pediatrics 1998; 102:1483-1491.
3. Centers for Disease Control and Prevention: Withdrawal of rotavirus vaccine recommendation. Morb Mortal Wkly Rep 1999; 48:1007.
4. Provisional Committee on Quality Improvement, Subcommittee on Acute Gastroenteritis: Practice parameter: the management of acute gastroenteritis in young children. Pediatrics 1996; 97:424-435.
5. Joensuu J, Koskenniemi E, Vesikari T: Symptoms associated with rhesus-human reassortant rotavirus vaccine in infants. Pediatr Infect Dis J 1998; 17:334-340.
6. Rennels MB, Parashar UD, Holman RC, Le CT, Chang H-G, Glass RI: Lack of an apparent association between intussusception and wild or vaccine rotavirus vaccine. Pediatr Infect Dis J 1998; 17:924-925.
7. Murphy TV, Gargiullo PM, Massoudi MS, et al: Intussusception among infants given an oral rotavirus vaccine. N Engl J Med 2001; 344:564-572.
8. Niu MT, Erwin DE, Braun MM: Data mining in the US Vaccine Adverse Events Reporting System (VAERS): early detection of intussusception and other events after rotavirus vaccination. Vaccine 2001; 19:4627-4634.
9. Singleton JA, Lloyd JC, Mootrey GT, et al: An overview of the vaccine adverse events reporting system (VAERS) as a surveillance system. Vaccine 1999; 17:2908-29017.
10. Geier MR, Geier DA: Hepatitis B vaccine and gastroenterologic adverse reactions. Hepatogastroenterology 2001; 48. (Letter)
11. Geier MR, Geier DA: Arthritic reactions and hepatitis B vaccination: an analysis of the vaccine adverse events reporting system (VAERS) from 1990 through 1997. Clin Exp Rheumatol 2000; 18:789-790.
12. Geier MR, Geier DA: Immunological reactions and hepatitis B vaccine. Ann Intern Med 2001; 134:1155.
13. Geier DA, Geier MR: Hepatitis B vaccination and adult associated gastrointestinal reactions: a followup analysis. Hepatogastroenterology 2002; 49:1571-1575.
14. Geier DA, Geier MR: Hepatitis B vaccination and arthritic adverse reactions: a follow-up analysis of the vaccine adverse events reporting system (VAERS) database from July 1990 through August 1999. Clin Exp Rheumatol 2002; 20:119.
15. Geier MR, Geier DA: Cutaneous immunological reactions to hepatitis B virus vaccine. Ann Intern Med 2002; 136:780-781.
16. Geier MR, Geier DA: Hepatitis B vaccine safety. Ann Pharmacotherapy 2002; 36:370-374.
17. Geier DA, Geier MR: An analysis of the reactivity of vaceines administered in the state of Texas from 1991 through 1999: based upon the vaccine adverse events reporting system (VAERS) database. Tex Med 2002; 98:50-54.
18. Geier DA, Geier MR: Rubella vaccine and arthritic adverse reactions: an analysis of the vaccine adverse events reporting system (VAERS) database from 1991 through 1998. Clin Exp Rheumatol 2001; 19:724-726.
19. Geier DA, Geier MR: Anthrax vaccination and joint related adverse reactions in light of biological warfare scenarios. Clin Exp Rheumatol 2002; 19:217-220.
20. Glass RI, Kilgore PE, Holman RC, et al: The epidemiology of rotavirus diarrhea in the United State: surveillance and estimates of disease burden. J Infect Dis 1996; 174(Suppl 1):S5-11.
21. Bresee JS, Glass RI, Ivanoff B, et al: Current status and future priorities for rotavirus vaccine development, evaluation and implementation in developing countries. Vaccine 1999; 17:2207-2222.
22. Kapikian AZ, Flores J, Hoshino Y, et al: Rotvirus: the major etiologic agent of severe infantile diarrhea may be controllable by a " Jennerian" approach to vaccination. J Infect Dis 1986; 153:815-822.
23. Clemens J, Keckich N, Naficy A, et al: Public health considerations for the introduction of new rotavirus vaccines for infants: a case study of tetravalent rhesus rotavirus-based reassortant vaccine. Epidemiol Rev 1999; 21:24-42.